	Fully automated AI-based quantification of tumour volume on PSMA PET-CT images is associated with overall survival in prostate cancer. Clin Physiol Funct Imaging Wittgren J, Ingvar J, Enqvist O, Larsson M, Minarik D, Edenbrandt L, Bjartell A, Trägårdh E. PMID: 42973055 [PubMed - indexed for MEDLINE]
	Five-Year Clinical Outcomes Following Nephrectomy for Renal Cell Carcinoma: Evidence From a Nationwide Japanese Surgical Registry. Int J Urol Mizuno R, Yamamoto K, Yamamoto H, Hatakeyama S, Sakamoto S, Yasui T, Kobayashi T, Kamoto T, Kikuchi E, Ito A, Kume H. PMID: 42972879 [PubMed - indexed for MEDLINE]
	Acute Lymphopenia and Recovery With Prophylactic Pelvic Nodal Radiotherapy in Oligometastatic Prostate Cancer: Interim Results From the Prospective PROLONG2 Cohort. Cancer Med Qi X, Wang H, Zhang H, Ren X, Ma M, Li X, Zhang W, He Z, Song Y, Shen C, Yu W, Fan Y, Gao X, Li H. PMID: 42972866 [PubMed - indexed for MEDLINE]
	Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter study. BMC Med Garofoli M, Natalicchio MI, Bruno G, Rosano A, Maiorano BA, Rossetti S, Scagliarini S, Incorvaia L, Formisano L, Toma I, Giordano G, Pecoraro G, Grillone F, Palumbo L, Pisino M, Palladino M, Di Pippo CR, Bafunno V, Brighi N, Casadei C, Lolli C, Cursano MC, Chiuri VE, Rescigno P, Tamburini E, Sanguedolce F, Calabrò F, De Giorgi U, Landriscina M, Conteduca V. PMID: 42972372 [PubMed - indexed for MEDLINE]
	When, where, and in whom does recurrence occur after radical cystectomy for pathologically confirmed non-muscle-invasive bladder cancer? Implications for risk-adapted surveillance. World J Urol Contieri R, de Angelis M, Scilipoti P, Pellegrino F, Longoni M, Afferi L, Zamboni S, Suardi N, Subiela JD, Musi G, Di Trapani E, Mistretta FA, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Beatrici E, De Groote R, Mottrie A, Rouprêt M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguié M, Bajeot AS, Mir MC, Umari P, Teoh JYC, Pichler R, Mori K, , Poyet C, Albisinni S, Aziz A, Shariat SF, Minervini A, Mari A, Lambertini L, Aveta A, Spena G, Izzo A, Montorsi F, Briganti A, Pradere B, van Rhijn BWG, Hurle R, Claps F, Perdonà S, PeMoschinirdonà M, Mertens LS, European Association of Urology. PMID: 42972136 [PubMed - indexed for MEDLINE]
	Difficulties with early prostate cancer diagnosis: a multi-perspective mixed-methods study. Br J Gen Pract Hiscock J, Formby L, Din N, Hendry A, Wilkinson CE. PMID: 42971714 [PubMed - as supplied by publisher]
	External Validation of Existing Nomograms on Indian Prostate Biopsy Data. Int J Urol Gupta M, Arulraj K, Kumar R. PMID: 42971147 [PubMed - indexed for MEDLINE]
	Predictive Nomogram for High Ki-67 Expression using Contrast-Enhanced Ultrasound of Clear Cell Renal Cell Carcinoma. J Imaging Inform Med Meng X, Yang Y, Yun Y, Shao Y, Jian Y, Sun Z. PMID: 42970198 [PubMed - as supplied by publisher]
	Pre-treatment machine learning prediction of local failure and time to local failure after Gamma Knife radiosurgery for radioresistant brain metastases. J Neurooncol Reyes JS, Shohayeb MAM, Bouras A, Lunsford LD, Hadjipanayis CG, Niranjan A. PMID: 42970176 [PubMed - indexed for MEDLINE]
	Robot-Assisted Radical Prostatectomy Using the Hugo RAS System: The First 15 Cases by a First-Year Novice Surgeon Without Prior Console Experiences. Int J Med Robot Yang CH, Barbulescu DV, Marian L, Kim YA, Wu CH, Narasimhan R, Ou YC, Lin CC. PMID: 42969321 [PubMed - indexed for MEDLINE]
	Real-World Early Prostate-Specific Antigen Response Comparison Among Patients with Metastatic Castration Sensitive Prostate Cancer Treated with Apalutamide or Abiraterone Acetate in the United States. J Health Econ Outcomes Res Lowentritt B, Bilen MA, Burbage S, Patel C, Kinkead F, Rossi C, Wong G, Pilon D, Shore N. PMID: 42968988 [PubMed]
	From Biopsy to Pathology: A Retrospective Cohort Study of Predictors of Gleason Score Upgrading in Grade Group 1 Prostate Cancer. Cancer Diagn Progn Su HC, Su YC, Lee HY, Juan YS, Wu WJ, Lu K. PMID: 42968951 [PubMed]
	Correction to "Chidamide (a Histone Deacetylase Inhibitor) Plus Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Phase Ib Trial". MedComm (2020) PMID: 42968886 [PubMed]
	Advances in Nanoparticle Technologies for Prostate Cancer Detection and Therapy. DNA Cell Biol Abdullo A, Kenjaev Y, Melibayeva R, Firdavs U, Firuza N, Giyos A. PMID: 42968472 [PubMed - as supplied by publisher]
	Non-Invasive Assessment of Perineural Invasion Density: A Novel Marker for Prognosis and Treatment Stratification in Prostate Cancer. Adv Sci (Weinh) Liu B, Zhang L, Zhu W, Yang M, Liu X, Li X, Qin P, Lin Z, Cai Q, Zheng J, Zhao X, Zou C, Wen X, Xu L, Wu D, Zhang L, Zhang C, Li K, Wang C, Zhong W, Luo Y. PMID: 42966879 [PubMed - as supplied by publisher]
	Bone fractures and prior abiraterone use in men treated with radium-223 plus enzalutamide for castration-resistant prostate cancer with bone metastases: a real-world study. Prostate Cancer Prostatic Dis McKay RR, Lunacsek O, Korn MJ, Raval AD. PMID: 42966775 [PubMed - as supplied by publisher]
	Treatment Effect of Perioperative (Neoadjuvant and Adjuvant) Apalutamide plus Androgen-deprivation Therapy Versus Radical Prostatectomy Alone in Patients with High-risk Localized or Locally Advanced Prostate Cancer from the PROTEUS Substudy. Eur Urol Briganti A, Steuber T, Shore ND, Gleave M, Kretschmer A, Wetherhold L, Efstathiou E, Cahn DJ, Damião R, De La Taille A, Byun SS, Hadaschik BA, Imbroda BH, Soto ÁJ, Merseburger AS, Simone G, Rooney B, Mikerin D, Li Z, Miladinovic B, McCarthy SA, Wildgust M, Mundle SD, Kibel AS, Taplin ME. PMID: 42966675 [PubMed - as supplied by publisher]
	A comparative study of effectiveness and safety of percutaneous cryoablation and microwave ablation of renal cell carcinoma. Clin Imaging Villalobos A, Xing M, Mohnasky M, Dabbous H, Aslanyan L, Lilly M, Bercu Z, Kokabi N. PMID: 42966350 [PubMed - as supplied by publisher]
	Long-Term Outcomes of Focal Irreversible Electroporation for Localized Prostate Cancer: Results of a Prospective Pilot Study With Extended Follow-up. Clin Genitourin Cancer Morozov A, Asali M, Matkovskiy I, Rivas JG, Singla N, Tsoy L, Fisenko E, Spivak L, Lokshin K, Rudenko V, Chinenov D, Barret E, Enikeev D. PMID: 42966034 [PubMed - as supplied by publisher]
	Correlation Between Androgen Receptor Expression and Prognosis in Prostate Cancer Patients: A Retrospective Study. J Vis Exp Lu J, Wu H. PMID: 42965378 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 182666

Page 1 of 9134



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy